NanoViricides Inc. (NNVC)

[BonelessCat]

There are 2 possibilities I see here (not that I'm suggesting this is the thinking of management):

1) If ebolacide is effective, tox studies could be completed under USAMRIID and for ebolacide. Once in humans pre-clinical studies are moot, especially if PK/PD is done by USAMRIID during the efficacy tests. USAMRIID already reported EbolaCide MOA and part of the PD.

2) Back to flucide and BASi if ebolacide gets the finger. That's why I think this strategy is a binary situation for NNVC.

NNVC will need to demonstrate an ability to manufacture at necessary volume if it works. Under the CRADA, USAMRIID can take over the technology if the company doesn't have the capacity to produce sufficient drug for emergency or military use.

There is a billion dollar jackpot for effective ebolacide candidates, of which NNVC could get a $100 million taste. Sure there's no money in Africa, but there is a huge amount from the NGOs and the US government.